Simba-Lahuasi, A.; Cantero-Camacho, Á.; Rosales, R.; McGovern, B.L.; Rodríguez, M.L.; Marchán, V.; White, K.M.; García-Sastre, A.; Gallego, J.
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals 2022, 15, 1448.
https://doi.org/10.3390/ph15121448
AMA Style
Simba-Lahuasi A, Cantero-Camacho Á, Rosales R, McGovern BL, Rodríguez ML, Marchán V, White KM, García-Sastre A, Gallego J.
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals. 2022; 15(12):1448.
https://doi.org/10.3390/ph15121448
Chicago/Turabian Style
Simba-Lahuasi, Alvaro, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M. Luis Rodríguez, Vicente Marchán, Kris M. White, Adolfo García-Sastre, and José Gallego.
2022. "SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules" Pharmaceuticals 15, no. 12: 1448.
https://doi.org/10.3390/ph15121448
APA Style
Simba-Lahuasi, A., Cantero-Camacho, Á., Rosales, R., McGovern, B. L., Rodríguez, M. L., Marchán, V., White, K. M., García-Sastre, A., & Gallego, J.
(2022). SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals, 15(12), 1448.
https://doi.org/10.3390/ph15121448